INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer—Toxicity Update on First 213 Patients
Prarabdh Singh, J.A. Efstathiou, M. Plets, Samyukta Jhavar, S. Delacroix, A. Tripathi, A. Gupta, S. Sachdev, A. Jani, A.N. Kirschner, C. Tangen, Rick Bangs, M. Joshi, B.A. Costello, I.L. Thompson, F.Y. Feng, S. Lerner
Topics & Concepts
MedicineAtezolizumabUrologyBladder cancerRegimenRadiation therapyGemcitabineOncologyInternal medicineRandomized controlled trialChemotherapyChemoradiotherapyCancerImmunotherapyPembrolizumabBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer Diagnosis and Treatment